Ensysce Biosciences, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Ensysce Biosciences, Inc. reported Cash And Cash Equivalents At Carrying Value of $4.31 million for the year ending 2025.

  • Ensysce Biosciences, Inc. showed an increase of +23.1% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Ensysce Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), Ensysce Biosciences, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 2,119.4%.
  • Historical annual values: Fiscal year 2025: $4.31 million | Fiscal year 2024: $3.50 million | Fiscal year 2023: $1.12 million | Fiscal year 2022: $3.15 million | Fiscal year 2021: $12.26 million | Fiscal year 2020: $194.2 thousand.
  • Data sourced from SEC EDGAR public filings as of June 24, 2026.

Last verified: